Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

Serum HBD2 is a marker of chronic spontaneous urticaria

July 16, 2021

DDX21 has prognostic impact in adrenocortical carcinoma

July 15, 2021

MicroRNAs identified as markers of response to benralizumab treatment

July 15, 2021

Complement system alternative pathway linked to worse outcome in hospitalized COVID-19 patients

July 15, 2021

MASP-2 levels tied to asthma severity

July 15, 2021

ACE2 and TLR7 are highly expressed in severe patients with COVID-19

July 14, 2021

miR-491-5p and miR-592 are downregulated in overactive bladder

July 14, 2021

High annexin-2 levels worsen lung injury in patients with COVID-19

July 13, 2021

Biomarker panel identifies cardiovascular risk and benefit from SGLT2 inhibitors

July 9, 2021

Newly identified lncRNA could be a biomarker of liver and pancreatic cancers

July 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...